Cargando…
Intravenous infusion umbilical cord-derived mesenchymal stem cell in primary immune thrombocytopenia: A two-year follow-up
Four patients with chronic refractory immune thrombocytopenic purpura (ITP) received human umbilical cord-derived mesenchymal stem cells (hUC-MSCs). The hUC-MSC dose was 5×10(7) to 1×10(8). Complete remission (CR) was achieved in three patients in 12 months and one patient in 24 months. Three patien...
Autores principales: | Wang, Xiaohua, Yin, Xiaoguang, Sun, Wei, Bai, Jin, Shen, Yawen, Ao, Qiang, Gu, Yongquan, Liu, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443306/ https://www.ncbi.nlm.nih.gov/pubmed/28565834 http://dx.doi.org/10.3892/etm.2017.4229 |
Ejemplares similares
-
Efficacy of umbilical cord-derived mesenchymal stem cell-based therapy for osteonecrosis of the femoral head: A three-year follow-up study
por: Chen, Chun, et al.
Publicado: (2016) -
Functional characterization of human umbilical cord-derived mesenchymal stem cells for treatment of systolic heart failure
por: Fang, Zhihua, et al.
Publicado: (2016) -
Clinical observation of umbilical cord mesenchymal stem cell treatment of severe idiopathic pulmonary fibrosis: A case report
por: Zhang, Chunyu, et al.
Publicado: (2017) -
Intravenous infusion of small umbilical cord mesenchymal stem cells could enhance safety and delay retinal degeneration in RCS rats
por: Liang, Qingling, et al.
Publicado: (2022) -
Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy])
por: Bartolucci, Jorge, et al.
Publicado: (2017)